Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine
A comprehensive approach addressing a broad range of risk factors, rather than solely focusing on clozapine, could be beneficial when evaluating and treating metabolic problems among people with TRS.
Authors
- Milan Dragović (ORCID: https://orcid.org/0000-0003-2604-0230)
- Alexander John (ORCID: https://orcid.org/0000-0002-1989-6578)
- Hitesh Prajapati
Institutions
- Bentley University (US)
- The University of Western Australia (AU)
- WA Country Health Service (AU)
- North Metropolitan Health Service (AU)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2025-08-15
- DOI
- https://doi.org/10.1097/jcp.0000000000002058
- Citations
- 2
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94